These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24224048)

  • 1. Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertension.
    Frump AL; Lowery JW; Hamid R; Austin ED; de Caestecker M
    PLoS One; 2013; 8(11):e80319. PubMed ID: 24224048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
    Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
    J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype effects of
    Frump AL; Datta A; Ghose S; West J; de Caestecker MP
    Pulm Circ; 2016 Dec; 6(4):597-607. PubMed ID: 28090303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
    Flynn C; Zheng S; Yan L; Hedges L; Womack B; Fessel J; Cogan J; Austin E; Loyd J; West J; Zhao Z; Hamid R
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):20-7. PubMed ID: 22312021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
    Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
    PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A; Kizhakkedath P; Al-Gazali L; Ali BR
    Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4PBA Restores Signaling of a Cysteine-substituted Mutant BMPR2 Receptor Found in Patients with Pulmonary Arterial Hypertension.
    Dunmore BJ; Yang X; Crosby A; Moore S; Long L; Huang C; Southwood M; Austin ED; Rana A; Upton PD; Morrell NW
    Am J Respir Cell Mol Biol; 2020 Aug; 63(2):160-171. PubMed ID: 32255665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.
    Talati M; West J; Blackwell TR; Loyd JE; Meyrick B
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L363-73. PubMed ID: 20562228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
    Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension.
    Li W; Dunmore BJ; Morrell NW
    Proc Am Thorac Soc; 2010 Nov; 7(6):395-8. PubMed ID: 21030519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.
    Hemnes AR; Brittain EL; Trammell AW; Fessel JP; Austin ED; Penner N; Maynard KB; Gleaves L; Talati M; Absi T; Disalvo T; West J
    Am J Respir Crit Care Med; 2014 Feb; 189(3):325-34. PubMed ID: 24274756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension.
    Johnson JA; Hemnes AR; Perrien DS; Schuster M; Robinson LJ; Gladson S; Loibner H; Bai S; Blackwell TR; Tada Y; Harral JW; Talati M; Lane KB; Fagan KA; West J
    Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(5):L474-84. PubMed ID: 22180660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcripts from a novel BMPR2 termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension.
    Hamid R; Hedges LK; Austin E; Phillips JA; Loyd JE; Cogan JD
    Clin Genet; 2010 Mar; 77(3):280-6. PubMed ID: 20095988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
    Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
    Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue.
    Sobolewski A; Rudarakanchana N; Upton PD; Yang J; Crilley TK; Trembath RC; Morrell NW
    Hum Mol Genet; 2008 Oct; 17(20):3180-90. PubMed ID: 18647753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele.
    Hamid R; Cogan JD; Hedges LK; Austin E; Phillips JA; Newman JH; Loyd JE
    Hum Mutat; 2009 Apr; 30(4):649-54. PubMed ID: 19206171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.